Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Chromosomal changes in primary myelodysplasias].

L I Iavorkovskiĭ, L Iu Riauzova, E Ia Soloveĭ

    Eksperimental'Naia Onkologiia
    |January 1, 1990
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Parvovirus B19 (PV-B19) and the human diseases it causes].

    Terapevticheskii arkhiv·1995
    Same author

    [The treatment of acute promyelocytic leukemia with retinoic acid].

    Terapevticheskii arkhiv·1994
    Same author

    [The Ph+ chromosome in acute leukemias (a review of the research on the molecular restructuring of the BCR gene)].

    Gematologiia i transfuziologiia·1993
    Same author

    [Reversibility of the development of malignant lymphoma with 7-years of leukemization, associated with the development of chronic myeloleukemia].

    Gematologiia i transfuziologiia·1991
    Same author

    [B12 (folic)-deficient anemia in a diabetic patient receiving buformin long term].

    Vrachebnoe delo·1991
    Same author

    [Malignant lymphoma with "hairy" lymphocytes in the blood and splenomegaly--a new variant of lymphoproliferative diseases].

    Gematologiia i transfuziologiia·1990

    This review examines chromosome abnormalities in myelodysplastic syndromes (MDS). It highlights how specific chromosomal changes impact disease progression and the risk of developing acute myeloid leukemia.

    Area of Science:

    • Cytogenetics
    • Hematology
    • Oncology

    Context:

    • Myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell disorders.
    • FAB classification categorizes MDS subgroups based on morphology.
    • Understanding genetic alterations is crucial for MDS management.

    Purpose:

    • To review and present data on chromosome abnormalities in different FAB-classified MDS subgroups.
    • To emphasize the prognostic significance of numerical and structural chromosomal changes during disease progression.
    • To discuss the correlation between specific chromosome aberrations, clinical course, and transformation to acute leukosis.

    Summary:

    • Literature data on chromosome abnormalities in FAB-classified myelodysplastic syndromes are compiled.

    Related Experiment Videos

  • Focus is placed on changes in chromosome number and structure and their prognostic implications.
  • The relationship between specific aberrations, clinical outcomes, and leukemic transformation is analyzed.

    • Impact:

    • Provides a comprehensive overview of cytogenetic findings in MDS.
    • Underscores the importance of karyotyping for predicting disease trajectory and risk of transformation.
    • Informs clinical decision-making and prognostic assessments in myelodysplastic syndromes.